Three‐Year Follow‐Up of the Phase II Trial for Resectable Non‐Small‐Cell Lung Cancer Treated With Perioperative Sintilimab and Neoadjuvant Anlotinib Plus Chemotherapy: TD‐NeoFOUR Trial.
Saved in:
| Title: | Three‐Year Follow‐Up of the Phase II Trial for Resectable Non‐Small‐Cell Lung Cancer Treated With Perioperative Sintilimab and Neoadjuvant Anlotinib Plus Chemotherapy: TD‐NeoFOUR Trial. |
|---|---|
| Authors: | Gao, Zhiyuan1 (AUTHOR), Mao, Yajie1 (AUTHOR), Sun, Yichen1 (AUTHOR), Tong, Liping1 (AUTHOR), Liu, Honggang1 (AUTHOR), Wang, Tianhu2 (AUTHOR), Shao, Changjian1 (AUTHOR) 15102905829@163.com, Duan, Hongtao1 (AUTHOR) 646041852@qq.com, Yan, Xiaolong1 (AUTHOR) yanxiaolong@fmmu.edu.cn |
| Source: | Thoracic Cancer. Aug2025, Vol. 16 Issue 16, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 187616606 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Three‐Year Follow‐Up of the Phase II Trial for Resectable Non‐Small‐Cell Lung Cancer Treated With Perioperative Sintilimab and Neoadjuvant Anlotinib Plus Chemotherapy: TD‐NeoFOUR Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Gao%2C+Zhiyuan%22">Gao, Zhiyuan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mao%2C+Yajie%22">Mao, Yajie</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Yichen%22">Sun, Yichen</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tong%2C+Liping%22">Tong, Liping</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Honggang%22">Liu, Honggang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Tianhu%22">Wang, Tianhu</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shao%2C+Changjian%22">Shao, Changjian</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> 15102905829@163.com</i><br /><searchLink fieldCode="AR" term="%22Duan%2C+Hongtao%22">Duan, Hongtao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> 646041852@qq.com</i><br /><searchLink fieldCode="AR" term="%22Yan%2C+Xiaolong%22">Yan, Xiaolong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> yanxiaolong@fmmu.edu.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Thoracic+Cancer%22">Thoracic Cancer</searchLink>. Aug2025, Vol. 16 Issue 16, p1-8. 8p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=187616606 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/1759-7714.70149 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 1 Titles: – TitleFull: Three‐Year Follow‐Up of the Phase II Trial for Resectable Non‐Small‐Cell Lung Cancer Treated With Perioperative Sintilimab and Neoadjuvant Anlotinib Plus Chemotherapy: TD‐NeoFOUR Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gao, Zhiyuan – PersonEntity: Name: NameFull: Mao, Yajie – PersonEntity: Name: NameFull: Sun, Yichen – PersonEntity: Name: NameFull: Tong, Liping – PersonEntity: Name: NameFull: Liu, Honggang – PersonEntity: Name: NameFull: Wang, Tianhu – PersonEntity: Name: NameFull: Shao, Changjian – PersonEntity: Name: NameFull: Duan, Hongtao – PersonEntity: Name: NameFull: Yan, Xiaolong IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 08 Text: Aug2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 17597706 Numbering: – Type: volume Value: 16 – Type: issue Value: 16 Titles: – TitleFull: Thoracic Cancer Type: main |
| ResultId | 1 |
